Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Blood Group Antigens | 1 | 2021 | 202 | 0.38 | Why? |
| Imatinib Mesylate | 1 | 2020 | 327 | 0.35 | Why? |
| Hematologic Neoplasms | 3 | 2021 | 2105 | 0.34 | Why? |
| Turkey | 11 | 2021 | 3937 | 0.33 | Why? |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 314 | 0.32 | Why? |
| Respiration, Artificial | 6 | 2021 | 22116 | 0.28 | Why? |
| Length of Stay | 5 | 2021 | 11042 | 0.20 | Why? |
| Thyroid Neoplasms | 1 | 2021 | 422 | 0.15 | Why? |
| Hospitalization | 7 | 2021 | 54280 | 0.15 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.14 | Why? |
| Genital Neoplasms, Female | 1 | 2020 | 718 | 0.13 | Why? |
| Retrospective Studies | 13 | 2021 | 105322 | 0.11 | Why? |
| Frail Elderly | 1 | 2020 | 1427 | 0.11 | Why? |
| Blood Glucose | 2 | 2021 | 3642 | 0.10 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2021 | 6166 | 0.10 | Why? |
| Frailty | 1 | 2020 | 1432 | 0.09 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.09 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.08 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.06 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.06 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.06 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.06 | Why? |
| Female | 13 | 2021 | 380317 | 0.06 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Iodine Radioisotopes | 1 | 2021 | 124 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Protein Kinase Inhibitors | 1 | 2020 | 1585 | 0.05 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.05 | Why? |
| Aged | 8 | 2021 | 215776 | 0.05 | Why? |
| Perioperative Period | 1 | 2020 | 276 | 0.05 | Why? |
| Adult | 8 | 2021 | 244371 | 0.05 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.04 | Why? |
| Antineoplastic Agents | 1 | 2020 | 3550 | 0.03 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2021 | 1316 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.03 | Why? |
| Geriatric Assessment | 1 | 2020 | 1372 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Databases, Factual | 1 | 2021 | 6248 | 0.02 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |